Breaching the fortress: Two-faced nanoparticles revive antibiotics against superbugs
en-GBde-DEes-ESfr-FR

Breaching the fortress: Two-faced nanoparticles revive antibiotics against superbugs


An international research team has demonstrated that Janus nanoparticles can disrupt the defenses of drug-resistant Gram-negative bacteria, restoring the effectiveness of conventional antibiotic treatments.

Osaka. Japan - In the global battle against antimicrobial resistance (AMR), an international research team has unveiled a powerful new game-changer. Using distinctive “two-faced” Janus nanoparticles, the team demonstrated a strategy that works in tandem with antibiotics to overcome the defenses of highly resistant Gram-negative bacteria. These particles disrupt the bacteria's protective outer membrane, creating an entry point for drugs that were previously ineffective and thereby reviving their life-saving potential.

Antimicrobial resistance is a severe global health crisis, with drug-resistant Gram-negative bacteria posing a particular challenge. These microbes are encased in a formidable outer membrane that acts as a shield, blocking many antibiotics from reaching their targets within the cell. This natural armor is a key reason why developing new drugs against them is so difficult and why existing ones are rapidly losing their power, leaving doctors with few treatment options.

Associate Professor Martijn Zwama and Professor Kunihiko Nishino led the research at the Institute of Scientific and Industrial Research (SANKEN), The University of Osaka, in collaboration with Professor Yan Yu (Indiana University, USA; current position: Washington University in St. Louis, USA), who led the design and engineering of the amphiphilic Janus nanoparticles (JNPs). Named after the two-faced Roman god, these particles have a dual nature: one side is hydrophilic (attracted to water) and the other is hydrophobic (repels water). This structure allows the JNPs to interact with and destabilize the bacterial outer membrane. While the JNPs themselves are not lethal to the bacteria, they effectively create pores or disruptions on the surface, compromising the cell's main defensive wall. This breach allows conventional antibiotic molecules, which were once blocked, to flood into the cell and execute their bacteria-killing function. This synergistic approach restored antibiotic activity against drug-resistant Gram-negative pathogens, including Escherichia coli and clinical isolates of Acinetobacter baumannii, a major cause of hospital-acquired infections.

This study offers a breakthrough materials-based strategy against antimicrobial resistance. By physically disrupting bacterial membranes, these nanoparticles are less susceptible to resistance evolution. They act as potent adjuvants, reviving and extending the lifespan of many existing antibiotics. This approach not only addresses a critical global health crisis but also opens doors for new clinical applications, such as antibacterial coatings, providing a versatile and high-impact tool to combat multidrug-resistant infections worldwide.

"These nanoparticles act as a perfect partner for antibiotics," says lead author Dr. Martijn Zwama. "They don't kill the bacteria directly but rather open the door for antibiotics to do their job. This synergy overcame resistance in some of the most stubborn bacteria. This approach of 'reviving' antibiotics offers a promising and sustainable path forward in tackling the AMR crisis."
###
The article, “Amphiphilic Janus Nanoparticles Synergize with Antibiotics to Restore Susceptibility in Drug-Resistant Gram-Negative Bacteria,” was published in Nano Letters at DOI: https://doi.org/10.1021/acs.nanolett.5c05337

About The University of Osaka
The University of Osaka was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world. Now, The University of Osaka is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
Title: Amphiphilic Janus Nanoparticles Synergize with Antibiotics to Restore Susceptibility in Drug-Resistant Gram-Negative Bacteria
Journal: Nano Letters
Authors: Martijn Zwama, Swagata Bhattacharyya, Nozomi Sakurai, Kunihiko Nishino, Yan Yu
DOI: 10.1021/acs.nanolett.5c05337
Funded by:
Japan Society for the Promotion of Science
Ministry of Education, Culture, Sports, Science and Technology
The Nippon Foundation
U.S. National Science Foundation
Article publication date: 11-NOV-2025
Archivos adjuntos
  • Fig. 1 Bacteria (gray) exhibit resistance to antibiotics (green spheres). However, when Janus nanoparticles (orange/gray spheres) are added, the antibiotics penetrate into the bacteria (red), leading to bacterial cell death.©Original content, Free to use for media and educational purposes with proper attribution., Zwama, M et al. Nano Lett. 25, 17244–17251, 2025
  • Fig. 2 The left panel shows Janus nanoparticles (JNPs) with an asymmetric structure. The center and right panels present a schematic illustration (blue = viable cells) and photographs (turbidity = viable cells) of bacterial growth under conditions where the concentrations of antibiotics and JNPs are varied from high to low. In the absence of JNPs, bacteria are killed at an antibiotic concentration of 64 µg/mL. In contrast, the addition of JNPs markedly reduces the antibiotic concentration required for bacterial killing. Higher JNP concentrations further decrease the antibiotic concentration needed to eliminate bacteria (green arrows).©Original content, Free to use for media and educational purposes with proper attribution., Martijn Zwama, The University of Osaka
Regions: Asia, Japan, North America, United States
Keywords: Health, Medical, Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement